Zyla Life Sciences Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 127

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $232M

Zyla Life Sciences General Information

Description

Provider of opioids and other pain care drugs designed for commercialization and development of abuse-resistant formulations. The company offers licensed and approved products indicated in adult patients for the short-term management of moderate to moderately severe pain for which alternative treatments are inadequate, enabling healthcare professionals to provide better opioid treatment to individuals.

Contact Information

Website
www.egalet.com
Formerly Known As
BM Research, Egalet
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 600 Lee Road
  • Suite 100
  • Wayne, PA 19087
  • United States
+1 (610)
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Corporate Office
  • 600 Lee Road
  • Suite 100
  • Wayne, PA 19087
  • United States
+1 (610)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zyla Life Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 20-May-2020 $232M Completed Generating Revenue
8. Bankruptcy: Admin/Reorg 30-Oct-2018 Completed Bankruptcy: Admin/Reorg
7. Secondary Transaction - Open Market 29-Mar-2018 Completed Generating Revenue
6. Secondary Transaction - Open Market 02-Jan-2018 Completed Generating Revenue
5. Secondary Transaction - Open Market 18-Apr-2016 Completed Generating Revenue
4. IPO 06-Feb-2014 Completed Generating Revenue
3. Later Stage VC 12-Sep-2013 Completed Generating Revenue
2. Debt - General 07-May-2012 $14.3M $41.9M Completed Generating Revenue
1. Early Stage VC (Series A) 14-Mar-2006 $27.6M $27.6M Completed Generating Revenue
To view Zyla Life Sciences’s complete valuation and funding history, request access »

Zyla Life Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of opioids and other pain care drugs designed for commercialization and development of abuse-resistant formulat
Drug Delivery
Wayne, PA
127 As of 2019

Solana Beach, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zyla Life Sciences Competitors (73)

One of Zyla Life Sciences’s 73 competitors is Sentynl Therapeutics, a Formerly PE-Backed company based in Solana Beach, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sentynl Therapeutics Formerly PE-Backed Solana Beach, CA
Neurelis Venture Capital-Backed San Diego, CA
Frenelle Pharma Venture Capital-Backed Plymouth, MN
Centrexion Therapeutics Venture Capital-Backed Boston, MA
Xalud Therapeutics Venture Capital-Backed New York, NY
You’re viewing 5 of 73 competitors. Get the full list »

Zyla Life Sciences Patents

Zyla Life Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019121686-A1 Oral delivery of active drug substances Inactive 18-Dec-2017
AU-2013285988-A1 Abuse deterrent pharmaceutical compositions for controlled release Inactive 06-Jul-2012
CA-2877183-A1 Abuse deterrent pharmaceutical compositions for controlled release Inactive 06-Jul-2012
EP-2877161-A1 Abuse deterrent pharmaceutical compositions for controlled release Inactive 06-Jul-2012
US-20140010873-A1 Abuse deterrent pharmaceutical compositions for controlled release Active 06-Jul-2012 A61K9/2031
To view Zyla Life Sciences’s complete patent history, request access »

Zyla Life Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zyla Life Sciences Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
4BIO Capital Venture Capital Minority
Atlas Venture Venture Capital Minority
Bio Fund Management Venture Capital Minority
CLS Capital Group Corporation Minority
DKA Capital PE/Buyout Minority
You’re viewing 5 of 14 investors. Get the full list »

Zyla Life Sciences Investments & Acquisitions (2)

Zyla Life Sciences’s most recent deal was a Corporate Asset Purchase with Iroko Pharmaceuticals (4 Non-Narcotic Pain Products). The deal was made on 04-Feb-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Iroko Pharmaceuticals (4 Non-Narcotic Pain Products) 04-Feb-2019 Corporate Asset Purchase Buildings and Property
Sprix 08-Jan-2015 Merger/Acquisition Pharmaceuticals
To view Zyla Life Sciences’s complete investments and acquisitions history, request access »

Zyla Life Sciences FAQs

  • When was Zyla Life Sciences founded?

    Zyla Life Sciences was founded in 1995.

  • Where is Zyla Life Sciences headquartered?

    Zyla Life Sciences is headquartered in Wayne, PA.

  • What is the size of Zyla Life Sciences?

    Zyla Life Sciences has 127 total employees.

  • What industry is Zyla Life Sciences in?

    Zyla Life Sciences’s primary industry is Drug Delivery.

  • Is Zyla Life Sciences a private or public company?

    Zyla Life Sciences is a Private company.

  • What is the current valuation of Zyla Life Sciences?

    The current valuation of Zyla Life Sciences is .

  • What is Zyla Life Sciences’s current revenue?

    The current revenue for Zyla Life Sciences is .

  • How much funding has Zyla Life Sciences raised over time?

    Zyla Life Sciences has raised $109M.

  • Who are Zyla Life Sciences’s investors?

    4BIO Capital, Atlas Venture, Bio Fund Management, CLS Capital Group, and DKA Capital are 5 of 14 investors who have invested in Zyla Life Sciences.

  • Who are Zyla Life Sciences’s competitors?

    Sentynl Therapeutics, Neurelis, Frenelle Pharma, Centrexion Therapeutics, and Xalud Therapeutics are some of the 73 competitors of Zyla Life Sciences.

  • When was Zyla Life Sciences acquired?

    Zyla Life Sciences was acquired on 20-May-2020.

  • Who acquired Zyla Life Sciences?

    Zyla Life Sciences was acquired by Assertio Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process